Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma Drives Swiss Growth Recovery After US Tariff Shock
Switzerland's pharmaceutical industry drove a recovery after outsized US tariffs plunged its export-focused economy into only the second contraction since the pandemic. Expansion of 1.9% among manufacturers of drugs and chemicals contributed…
Ligand Pharma (LGND) Earnings Call Transcript
Thursday, February 26, 2026 at 8:30 a.m. ET Chief Executive Officer — Todd Davis Chief Financial Officer — Octavio Espinoza Vice President, Portfolio Strategy and Investments — Lauren Hay Senior Director, Investor Relations…
Rhythm Pharma (RYTM) Earnings Call Transcript
Thursday, Feb. 26, 2026 at 8 a.m. ET Chairman, Chief Executive Officer, and President — David P. Meeker Executive Vice President, Head of North America — Jennifer Lee Chief Financial Officer — Hunter C. Smith Executive Vice…
Blue Jet Healthcare to set Rs ₹2,300 cr pharma plant AP
Blue Jet Healthcare is setting up a greenfield pharmaceutical manufacturing facility at Rambilli Industrial Park in Anakapalli district, Andhra Pradesh. The ground-breaking ceremony of the plant will take place on February 28, 2026. The Rambilli…
Eugia Pharma gets USFDA nod for Everolimus tablets
Eugia Pharma Specialities, an arm of Aurobindo Pharma, has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Everolimus tablets. The approved drug is a bioequivalent and therapeutically equivalent to…
Short Interest in Royalty Pharma PLC (NASDAQ:RPRX) Declines By 49.2%
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 13th, there was short interest totaling 13,443,797 shares, a drop of 49.2% from the January 29th…
Artisan Partners Limited Partnership Has $739.75 Million Stock Position in Ascendis Pharma A/S $ASND
Artisan Partners Limited Partnership lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 6.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Nifty Slips Toward 25,300 as Banking and IT Lead Broad-Based Market Sell-off
Indian equity benchmarks extended losses through early trade, with the BSE Sensex falling 520 points, or 0.63%, to 81,728 at 10:50 am, while the NSE Nifty 50 slipped 155 points, or 0.61%, to trade near 25,340. The broader market mirrored the…
Orion Group Financial Statement documents 2025 and Remuneration Report published
STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT Orion Group Financial Statement documents 2025 and Remuneration Report published Orion Group's Financial Statement documents for 2025 have been published. The documents are available in…
/afaqs/media/media_files/2026/02/27/zydus-2026-02-27-00-39-42.png)
Zydus to join GLP-1 rush with a reusable jab
Zydus Lifesciences' plan to launch reusable semaglutide injections in India following the medication's patent expiry marks the next phase of an intensifying race among weight loss drugmakers, one that is increasingly playing out across advertising…
GoodRx (GDRX) Q4 2025 Earnings Call Transcript
Thursday, Feb. 26, 2026 at 8 a.m. ET Chief Executive Officer — Wendy Barnes Chief Financial Officer — Chris McGinnis Chief Commercial Officer and President of Pharma Direct — Laura Jensen Need a quote from a Motley Fool…
Stock Market Today: Sensex, Nifty50 End Mixed In Volatile Trade
Indian stock markets experienced a day of seesaw trading as Sensex and Nifty ended nearly flat, influenced by global market cues, US-Iran talks, and strategic profit-booking. Sensex and Nifty ended almost flat after a volatile trading session…
Aurobindo arm's copy of Novartis drug gets U.S. FDA nod
Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Everolimus Tablets in different strengths. The product is bioequivalent and…
Truist Securities Downgrades Harmony Biosciences Holdings, Inc. (HRMY) to Hold After Patent Trial Developments
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is among the 20 Best Investments in 2026. Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best investment stocks on our list. TheFly reported on February 20 that Truist Securities…
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
Issued on behalf of Helus Pharma VANCOUVER, BC, Feb. 26, 2026 /CNW/ -- USA News Group News Commentary – The first psilocybin compound to achieve two positive Phase 3 results in treatment-resistant depression cleared that milestone this week…
Receive a Daily briefing on Pharma Industry News
Get Started